ctrl K

Price Alert

Rein Therapeutics Inc. (RNTX)

NASDAQ: RNTX · Real-Time Price · USD

1.11

-0.02 (-1.77%)

At close: Aug 19, 2025, 12:04 PM

Rein Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-48.42M	-42.82M	-29.61K	-25.52K	-18.47K	-11.27K	-3.98K	-1.99K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-47.93M	-42.43M	-29.24K	-25.22K	-18.07K	-10.95K	-3.61K	-1.79K
Net Income	-46.5M	-41M	-29.24K	-25.22K	-18.07K	-10.95K	-3.61K	-1.79K
Selling & General & Admin	5.04M	2.49M	16.72K	16.32K	12.92K	9.18K	3.85K	1.89K
Research & Development	6.38M	3.33M	12.9K	9.2K	5.64K	2.18K	209.00	187.00
Other Expenses	37M	37M	-12	-6	-94	-94	-82	-88
Operating Expenses	48.42M	42.82M	29.61K	25.52K	18.47K	11.27K	3.98K	1.99K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	54.49M	48.88M	6.09M	25.52K	18.47K	11.27K	3.98K	1.99K
Income Tax Expense	-1.54M	-1.54M	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	2.19K	21.69K	21.66K	19.91K	8.3K	4.77K	4.54K	4.54K
Shares Outstanding (Diluted)	2.19K	21.69K	21.66K	19.91K	8.3K	4.77K	4.54K	4.54K
EPS (Basic)	-2.51K	-3.47	-3.12	-3.25	-3.19	-2.33	-0.79	-0.39
EPS (Diluted)	-2.51K	-3.47	-3.12	-3.25	-3.19	-2.33	-0.79	-0.39
EBITDA	-5.63M	-28.05K	-29.5K	-25.4K	-18.43K	-11.28K	-4.03K	-2.07K
EBIT	-11.42M	-5.82M	-29.62K	-25.52K	-18.56K	-11.36K	-4.06K	-2.08K
Depreciation & Amortization	5.79M	5.79M	115.00	127.00	135.00	76.00	24.00	12.00